N-{3-[1-(4-amino-3-hydroxy-phenyl)-1-ethyl-propyl]-1H-indol-7-yl}-methanesulfonamide 、 原甲酸三乙酯 反应 3.0h,
以to afford the title compound (235 mg, 71%) as a yellow solid的产率得到N-[3-(1-benzooxazol-6-yl-1-ethyl-propyl)-1H-indol-7-yl]-methanesulfonamide
参考文献:
名称:
Indole-derivative modulators of steroid hormone nuclear receptors
[EN] INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS<br/>[FR] MODULATEURS A BASE DE DERIVES INDOLIQUES DES RECEPTEURS NUCLEAIRES DES HORMONES STEROIDES
申请人:LILLY CO ELI
公开号:WO2004067529A1
公开(公告)日:2004-08-12
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient, and methods for treating physiological disorders, particularly congestive heart disease, comprising administering to a patient in thereof an effective amount of a compound of Formula I.